LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
MERRILL LYNCH CUTS PEARSON TO 'NEUTRAL' ('BUY')
----------
JPMORGAN CUTS PEARSON TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 1,080 (1,365) PENCE
----------
KEPLER CHEUVREUX CUTS PEARSON PRICE TARGET TO 1300 (1400) PENCE - 'BUY'
----------
NOMURA CUTS PEARSON PRICE TARGET TO 1100 (1280) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS PEARSON PRICE TARGET TO 950 (1045) PENCE - 'SELL'
----------
JEFFERIES RAISES RECKITT BENCKISER PRICE TARGET TO 7100 (6750) PENCE - 'BUY'
----------
LIBERUM RAISES RECKITT BENCKISER PRICE TARGET TO 6800 (6660) PENCE - 'BUY'
----------
EXANE BNP RAISES RECKITT BENCKISER PRICE TARGET TO 6900 (6600) PENCE - 'OUTPERFORM'
----------
DEUTSCHE BANK RAISES RECKITT BENCKISER PRICE TARGET TO 6500 (6400) PENCE - 'BUY'
----------
PANMURE CUTS TRAVIS PERKINS PRICE TARGET TO 1650 (1950) PENCE - 'SELL'
----------
EXANE BNP RAISES SKY PLC PRICE TARGET TO 1050 (1000) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS GLAXOSMITHKLINE PRICE TARGET TO 1400 (1420) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BHP BILLITON PRICE TARGET TO 1300 (1360) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ARM PRICE TARGET TO 950 (850) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS HSBC PRICE TARGET TO 640 (670) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
PANMURE CUTS SIG PRICE TARGET TO 195 (226) PENCE - 'BUY'
----------
PANMURE CUTS SENIOR PLC TO 'HOLD' ('BUY') - TARGET 293 (402) PENCE
----------
JPMORGAN CUTS ACACIA MINING PRICE TARGET TO 300 (310) PENCE - 'OVERWEIGHT'
----------
EXANE BNP CUTS HOME RETAIL PRICE TARGET TO 115 (145) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS HOME RETAIL PRICE TARGET TO 130 (150) PENCE - 'HOLD'
----------
NOMURA CUTS HOME RETAIL PRICE TARGET TO 170 (200) PENCE - 'BUY'
----------
HSBC CUTS HOME RETAIL PRICE TARGET TO 1,800 (2,350) PENCE - 'BUY'
----------
HSBC CUTS PENNON GROUP PRICE TARGET TO 9,150 (9,500) PENCE - 'BUY'
----------
GOLDMAN RAISES TED BAKER PRICE TARGET TO 3560 (3530) PENCE - 'BUY'
----------
GOLDMAN RAISES SHAWBROOK PRICE TARGET TO 390 (370) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES PROVIDENT FINANCIAL PRICE TARGET TO 3370 (2970) PENCE - NEUTRAL
----------
GOLDMAN RAISES POLYMETAL PRICE TARGET TO 620 (570) PENCE - 'BUY'
----------
GOLDMAN INITIATES CENTAMIN WITH 'CONVICTION BUY LIST'
----------
TRADERS: CREDIT SUISSE CUTS HAYS TO 'NEUTRAL' ('OUTPERFORM')
----------
MAIN MARKET AND AIM
----------
NUMIS RAISES MOTHERCARE TO 'BUY' ('ADD') - TARGET 300 (320) PENCE
----------
NUMIS CUTS CAMBIAN PRICE TARGET TO 320 (380) PENCE - 'BUY'
----------
JPMORGAN RAISES LONMIN PRICE TARGET TO 35 (30) PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS ARROW GLOBAL PRICE TARGET TO 360 (380) PENCE - 'BUY'
----------
TRADERS: CREDIT SUISSE CUTS STHREE TO 'NEUTRAL' ('OUTPERFORM')
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
Fate of most remaining Zantac lawsuits weighed by Delaware judge
Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.
Read more